Renol Polychem Complete Financial Statements

In FYNone, Renol Polychem (RNPL) reported revenue ₹29 Cr, net profit ₹2 Cr and EPS ₹4.00, with a net profit margin of 7.9% and ROE of 38.5%. Full financial statements from FY2024 to FY2025 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see RNPL stock live price.

2 Years of Data
2025 - 2024

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.94% 2025 data
EBITDA Margin 11.11% 2025 data
Operating Margin 11.00% 2025 data
Return on Assets 21.74% 2025 data
Return on Equity 38.46% 2025 data

Balance Sheet Ratios

Equity Ratio 56.52% 2025 data
Asset Turnover 2.74 2025 data

RNPL Revenue, Net Profit & EBITDA — Year-on-Year Growth

RNPL YoY (March 2025 vs Period) — revenue -54.0%, net profit -60.0%, EBITDA -57.1%, expenses -52.7%.

Revenue Growth
-54.0%
Year-over-Year
Net Profit Growth
-60.0%
Year-over-Year
EBITDA Growth
-57.1%
Year-over-Year
Expense Growth
-52.7%
Year-over-Year
Assets Growth
+43.8%
Year-over-Year
Equity Growth
+44.4%
Year-over-Year
Operating Cash Flow Growth
-200.0%
Year-over-Year

RNPL Income Statement — Revenue, EBITDA & Net Profit

Renol Polychem revenue ₹29 Cr, EBITDA ₹3 Cr, net profit ₹2 Cr, EPS ₹4.00 (None) — net profit margin 7.9%. Explore RNPL intrinsic value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024
Revenue 29 63 7
Expenses 26 55 4
EBITDA 3 7 2
Operating Profit Margin % 5.00% 11.00% 35.00%
Depreciation 0 0 0
Interest 0 1 0
Profit Before Tax 3 7 2
Tax 1 2 1
Net Profit 2 5 2
Earnings Per Share (₹) 4.00 9.10 2.79

RNPL Balance Sheet — Assets, Liabilities & Shareholders' Equity

RNPL total assets ₹23 Cr, total equity ₹13 Cr, total liabilities ₹ Cr (2025) — ROE 38.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 23 16
Current Assets 22 15
Fixed Assets 0 0
Capital Work in Progress 0 0
Investments 0 0
Other Assets 23 15
LIABILITIES
Total Liabilities
Current Liabilities 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 13 9
Share Capital 6 6
Reserves & Surplus 8 3

RNPL Cash Flow Statement — Operating, Investing & Financing

Renol Polychem operating cash flow ₹-1 Cr, investing ₹0 Cr, financing ₹4 Cr, net cash flow ₹2 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities -1 1
Investing Activities 0 0
Financing Activities 4 0
Net Cash Flow 2 1